Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy

INTRODUCTION: The rate of adverse renal events has been shown to be higher in patients treated with lesinurad plus a xanthine-oxidase inhibitor (XOI) than in patients treated only with a XOI. We reassessed the risks for various adverse renal events from a different perspective and devised a hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez-Ruiz, Fernando, Jansen, Tim L., Tausche, Anne-Kathrin, Richette, Pascal, Lioté, Frédéric, So, Alexander K., Stack, Austin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393267/
https://www.ncbi.nlm.nih.gov/pubmed/30767124
http://dx.doi.org/10.1007/s40744-019-0143-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393267/
https://www.ncbi.nlm.nih.gov/pubmed/30767124
http://dx.doi.org/10.1007/s40744-019-0143-9

Ejemplares similares